Vanguard Group Inc ownership in 8AP / Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.

DE ˙ DB ˙ US00847X1046

€ 23,40 ↑0.80 (3.54%)

2026-06-04
PREÇO DA AÇÃO

Security	DE:8AP / Agios Pharmaceuticals, Inc.
Institution	Vanguard Group Inc
Latest Disclosed Ownership	0 shares
Ownership	0.00%

2026-03-26 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Agios Pharmaceuticals, Inc. (DE:8AP). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-02-12 , Vanguard Group Inc had reported owning 5,599,917 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2026-03-26	2026-03-26	13G/A	5,599,917	0	-100.00	0.00	-100.00
2024-02-12	2024-02-12	13G/A	5,335,076	5,527,438	3.61	9.89	1.85
2024-02-12	2024-02-12	13G/A	5,335,076	5,599,917	4.96	10.02	3.19
2023-02-09	2023-02-09	13G/A	5,068,590	5,335,076	5.26	9.71	4.07
2022-02-09	2022-02-09	13G/A	5,484,574	5,068,590	-7.58	9.33	-7.62
2021-12-09	2021-12-09	13G/A	5,625,713	5,484,574	-2.51	10.10	24.38
2021-02-10	2021-02-10	13G/A	5,606,855	5,625,713	0.34	8.12	-0.98
2020-02-12	2020-02-12	13G/A	4,621,949	5,606,855	21.31	8.20	3.27
2019-02-11	2019-02-11	13G/A	3,302,096	4,621,949	39.97	7.94	17.28
2018-02-08	2018-02-08	13G/A	2,468,232	3,302,096	33.78	6.77	15.33
2017-02-09	2017-02-09	13G		2,468,232		5.87

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-01-29	2025-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,594,353	-10,523	-0.19	152,278	-32.31	0.0022
2025-11-07	2025-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,604,876	-77,143	-1.36	224,980	19.05	0.0034
2025-08-11	2025-06-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,682,019	77,428	1.38	188,984	15.08	0.0031
2025-05-09	2025-03-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,604,591	-26,730	-0.47	164,215	-11.26	0.0030
2025-02-11	2024-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,631,321	85,339	1.54	185,045	-24.90	0.0032
2024-11-13	2024-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,545,982	49,245	0.90	246,408	3.96	0.0044
2024-08-13	2024-06-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,496,737	-75,284	-1.35	237,019	45.48	0.0046
2024-05-10	2024-03-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,572,021	44,583	0.81	162,926	32.36	0.0032
2024-03-11	2023-12-31	13F/A-1	AGIOS PHARMACEUTICALS	COM	00847X104	5,527,438	59,851	1.09	123,096	-9.03	0.0027
2024-02-14	2023-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,527,438	59,851		123,096		0.0023
2023-12-18	2023-09-30	13F/A-1	AGIOS PHARMACEUTICALS	COM	00847X104	5,467,587	-52,000	-0.94	135,323	-13.43	0.0033
2023-11-14	2023-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,467,587	-52,000		135,323		0.0006
2023-08-14	2023-06-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,519,587	95,660	1.76	156,315	25.47	0.0037
2023-07-14	2023-03-31	13F/A-1	AGIOS PHARMACEUTICALS	COM	00847X104	5,423,927	88,851	1.67	124,588	-16.84	0.0032
2023-05-15	2023-03-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,423,927	88,851		124,588		0.0032
2023-02-10	2022-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,335,076	109,979	2.10	149,809	1.38	0.0041
2022-11-14	2022-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,225,097	21,396	0.41	147,766	28.08	0.0043
2022-08-12	2022-06-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,203,701	117,887	2.32	115,366	-22.08	0.0032
2022-05-13	2022-03-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,085,814	17,224	0.34	148,048	-11.14	0.0035
2022-02-14	2021-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,068,590	-377,231	-6.93	166,605	-33.71	0.0038
2021-11-12	2021-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,445,821	-144,585	-2.59	251,326	-18.42	0.0062
2021-08-13	2021-06-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,590,406	-139,938	-2.44	308,088	4.11	0.0077
2021-05-14	2021-03-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,730,344	104,631	1.86	295,914	21.39	0.0080
2021-02-12	2020-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,625,713	117,536	2.13	243,762	26.44	0.0071
2020-11-16	2020-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,508,177	-236,733	-4.12	192,785	-37.25	0.0064
2020-08-14	2020-06-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,744,910	59,106	1.04	307,237	52.30	0.0109
2020-05-15	2020-03-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,685,804	78,949	1.41	201,731	-24.65	0.0086
2020-02-14	2019-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	5,606,855	815,666	17.02	267,727	72.47	0.0091
2019-11-14	2019-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	4,791,189	152,420	3.29	155,234	-32.91	0.0058
2019-08-14	2019-06-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	4,638,769	-7,449	-0.16	231,381	-26.16	0.0087
2019-05-15	2019-03-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	4,646,218	24,269	0.53	313,341	47.03	0.0123
2019-02-14	2018-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	4,621,949	370,510	8.71	213,119	-35.00	0.0096
2018-12-13	2018-09-30	13F/A-2	AGIOS PHARMACEUTICALS	COM	00847X104	4,251,439	109,849	2.65	327,871	-6.01	0.0128
2018-11-23	2018-09-30	13F/A-1	AGIOS PHARMACEUTICALS	COM	00847X104	4,251,439	0		327,871		0.0128
2018-11-14	2018-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	4,251,439	109,849		327,871
2018-08-14	2018-06-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	4,141,590	141,169	3.53	348,847	6.63	0.0146
2018-05-15	2018-03-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	4,000,421	698,325	21.15	327,155	73.30	0.0143
2018-02-14	2017-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	3,302,096	11,929	0.36	188,781	-14.04	0.0083
2017-11-14	2017-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	3,290,167	75,397	2.35	219,619	32.78	0.0103
2017-08-24	2017-06-30	13F/A-1	AGIOS PHARMACEUTICALS	COM	00847X104	3,214,770	617,379	23.77	165,401	9.04	0.0081
2017-08-11	2017-06-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	3,214,770	617,379		165,401
2017-05-12	2017-03-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	2,597,391	129,159	5.23	151,688	47.27	0.0078
2017-02-14	2016-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	2,468,232	104,011	4.40	103,000	-17.52	0.0057
2016-11-14	2016-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	2,364,221	258,630	12.28	124,879	41.56	0.0073
2016-08-10	2016-06-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	2,105,591	192,852	10.08	88,214	13.59	0.0055
2016-05-13	2016-03-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	1,912,739	48,726	2.61	77,657	-35.83	0.0050
2016-02-08	2015-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	1,864,013	1,845,178	9,796.54	121,012	8,998.65	0.0081
2015-11-12	2015-09-30	13F/A-1	AGIOS PHARMACEUTICALS	COM	00847X104	18,835	-1,602,727	-98.84	1,330	-99.26	0.0001
2015-11-12	2015-09-30	13F/A-1	AGIOS PHARMACEUTICALS	COM	00847X104	3,594,801	1,973,239		253,758		0.0108
2015-11-12	2015-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	11,133,088			500,106
2015-08-13	2015-06-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	1,621,562	34,243	2.16	180,221	20.40	0.0122
2015-05-15	2015-03-31	13F/A-1	AGIOS PHARMACEUTICALS	COM	00847X104	1,587,319	295,617	22.89	149,685	3.43	0.0102
2015-05-14	2015-03-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	1,587,319			149,685
2015-02-12	2014-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	1,291,702	212,194	19.66	144,722	118.52	0.0104
2014-11-12	2014-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	1,079,508	220,819	25.72	66,227	68.32	0.0052
2014-08-11	2014-06-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	858,689	104,905	13.92	39,345	33.32	0.0031
2014-05-13	2014-03-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	753,784	507,872	206.53	29,511	401.12	0.0025
2014-02-12	2013-12-31	13F	AGIOS PHARMACEUTICALS	COM	00847X104	245,912	-24,797	-9.16	5,889	-22.20	0.0005
2013-11-07	2013-09-30	13F	AGIOS PHARMACEUTICALS	COM	00847X104	270,709	270,709		7,569		0.0007

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.